Lipoprotein (a) is not associated with thrombus burden derived from CT pulmonary angiography in patients with acute pulmonary embolism

Paul Gressenberger,Florian Posch,Gabriel Adelsmayr,Eszter Nagy,Ann-Katrin Kaufmann-Bühler,Jakob Steiner,Michael Janisch,Clemens Reiter,Martin Eibisberger,Elmar Janek,Nina Softic,Michael Fuchsjäger,Katharina Gütl,Philipp Jud,Günther Silbernagel,Reinhard B. Raggam,Marianne Brodmann,Thomas Gary,Johannes Schmid
DOI: https://doi.org/10.1038/s41598-024-77669-z
IF: 4.6
2024-10-31
Scientific Reports
Abstract:Lipoprotein (a) [Lp(a)] is suspected to have antifibrinolytic effects, however, its relevance for the severity of venous thromboembolic events remains unclear. We studied the association of Lp(a) levels with thrombus load in pulmonary embolism (PE). 90 patients (40% female, median age 70 [56–79] years) at our tertiary care hospital with a diagnosis of acute PE, available Lp(a) levels and CT pulmonary angiography (CT-PA) performed between April 2017 and December 2019 were included. All CT-PA scans were reanalyzed and thrombus load was determined via Qanadli CT obstruction index (CTOI) and most proximal thrombus location. Median Lp(a) levels were 11.4 [9.3–29.1] mg/dL, median D-dimer levels were 4.6 [2.1–9.8] mg/L, median CTOI was 23 [8–50], central PE was present in 27 (30%) patients. Lp(a) did not correlate with CTOI ( r = 0.02, p = 0.922) and was not associated with thrombus location ( p = 0.369). CTOI significantly correlated with D-dimer ( r = 0.43, p < 0.001) and right to left ventricular diameter ratio ( r =-0.49, p = < 0.001). Our findings showed that Lp(a) is not associated with thrombus burden in PE, which suggests that a relevant effect of Lp(a) on the extent of venous thromboembolism is unlikely.
multidisciplinary sciences
What problem does this paper attempt to address?